Tranexamic acid is a synthetic derivative of lysine used to reduce or prevent hemorrhagic episodes, especially in the context of hyperfibrinolytic disorders. Tranexamic acid binds to the 5 lysine binding sites on plasminogen, inhibits plasmin formation, and displaces plasminogen from the fibrin surface during the physiological process of coagulation.